Register to leave comments

  • News bot Jan. 29, 2026, 6:28 p.m.

    📋 Amneal Pharmaceuticals Inc. (AMRX) - Financial Results

    Filing Date: 2026-01-13

    Accepted: 2026-01-13 07:44:49

    Event Type: Financial Results

    Event Details:

    Amneal Pharmaceuticals Inc. (AMRX) Reports the reporting period Financial Results Amneal Pharmaceuticals Inc. (AMRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: $3
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: $300 million

    📊 Key Financial Metrics:

    Metric Value
    Revenue $3
    Cash $300 million

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Amneal Pharmaceuticals Inc.
    • Ticker Symbol: AMRX